Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_provenance.
- NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_assertion description "[We have used Northern blot analysis to detect mRNA from class I HLA genes in the human choriocarcinoma cell line BeWo, which has been previously shown to express an atypical HLA class I molecule, in the absence of HLA A and B. Hybridization was seen with three class I DNA probes, the strongest being seen with the probe pC800, which corresponds to an 800-bp section of the Cw3 gene.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_provenance.
- NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_assertion evidence source_evidence_literature NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_provenance.
- NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_assertion SIO_000772 2708822 NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_provenance.
- NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_assertion wasDerivedFrom befree-2016 NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_provenance.
- NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_assertion wasGeneratedBy ECO_0000203 NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_provenance.
- befree-2016 importedOn "2016-02-19" NP1296255.RAMePmr8BhZVGi_om0Sqzo3Kwtp55Lhd4Ux5DTCT-PG1s130_provenance.